Apollo Medical EPS beats by $0.23, beats on revenue; raising FY20 guidance

• Apollo Medical (NASDAQ:AMEH): Q3 GAAP EPS of $0.45 beats by $0.23.
• Revenue of $180.1M (+15.4% Y/Y) beats by $12.83M.
• FY20 guidance: Total revenue of $665.0M-$675.0M vs consensus of $670.8M, raising net income of $110.0M-$120.0M from previously announced $100.0M-$110.0M; raising EBITDA to $182.0M-$194.0M from previously announced $155.0M- $167.0M and adjusted EBITDA to $97.0M-$112.0M from previously announced $75.0M-$90.0M.
• Press Release
• https://seekingalpha.com/news/3631698-apollo-medical-eps-beats-0_23-beats-on-revenue-raising-fy20-guidance